DPY19L2P2
Putative C-mannosyltransferase DPY19L2P2
Also known as: D19P2_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for DPY19L2P2 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
376 residues, UniProt reviewed canonical sequence.
>Q6ZN68|DPY19L2P2
1 MADSRRVIIA SWYRTFMGIV NLFGLETKTC WNVTRIEPLN EVQSCEGLRD PACFYVGVIF
61 ILNGLMMGLF FIYGTYLSGT ELGGLITVLC FFFNHGEATC VMWTPPLRES FSYPFLVLQM
121 YVLTLILRTS SNDRRPFIAL CLSNVAFMLP WQFAQFILFT QIASLFPMYV VGYIEPSKFQ
181 KIIYMNMISV TLSFILMFGN SMYLSSYYSS SLLMTWAIIL KRNEIQKLGV SKLNCWLIQG
241 SAWWCGTIIL KFLTSKILGV SDHICLSDLI AAGILRYTDF DTLKYTCSPE FDFMEKATLL
301 IYTKTLLLPV VMVITCFIFK KTVGDISRVL ATNVYLRCCL CRCHAYNGKC QAVYTSSHCE
361 SSTLRRCRLE AWLQHALocalizationUniProt · AlphaFold · HPA
Whether an antibody against DPY19L2P2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.34
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DPY19L2P2 as an antibody target. Whether an autoantibody or antibody against DPY19L2P2 could matter depends on whether native DPY19L2P2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DPY19L2P2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DPY19L2P2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...